Insider · CIK 0001826902
David S. Wood
Files at EPIX (ESSA Pharma Inc.). First filing -, latest -.
In brief
David S. Wood files SEC Form 4 as CFO at EPIX (ESSA Pharma Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David S. Wood has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | EPIX ESSA Pharma Inc. | DDisposition to issuer Common Shares | -33,343 | - | - | 0 | Oct 15, 2025 |
| Oct 24, 2023 | EPIX ESSA Pharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,750 | $0.00 | $0 | 3,750 | Nov 24, 2023 |
Questions about David S. Wood
Answered from the filings on this page, as of the latest one.
Is David S. Wood buying or selling?
David S. Wood has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David S. Wood's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David S. Wood has 0.
Where does David S. Wood file Form 4?
David S. Wood has filed Form 4 at EPIX (ESSA Pharma Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.